FGFR2 and central nervous system cancer: The current results showed that alterations in CDK4, CDK6, CDKN2A, EGFR, FGFR2, FGFR3, KIT, NF1, NTRK2, and RB1 were correlated with a short OS in gliomas (Figure 5).